Related Experiment Videos
Gadolinium-containing copolymeric chelates--a new potential MR contrast agent
Magma (New York, N.Y.)
|September 30, 1999
Summary
New gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) copolymers show improved vascular enhancement for MR angiography. These blood pool contrast agents offer sustained enhancement confined to blood vessels, unlike standard Gd-DTPA.
Area of Science:
- Biomedical Engineering
- Radiology
- Materials Science
Background:
- Magnetic Resonance (MR) contrast agents enhance image quality.
- Gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) is a common MR contrast agent.
- Development of targeted blood pool agents is an active research area.
Purpose of the Study:
- To develop and characterize novel polymeric MR contrast agents.
- To evaluate their performance in MR angiography (MRA).
Main Methods:
- Synthesized Gd-DTPA copolymers with varying molecular weights of polyethylene glycol (PEG) or polypropylene glycol (PPG).
- Determined gadolinium content and measured relaxivity (r1) at 1.5 Tesla.
- Performed MRA in rabbits comparing Gd-copolymers with Gd-DTPA.
Main Results:
- Gd-copolymers exhibited moderate increases in relaxivity compared to Gd-DTPA.
- In vivo MRA in rabbits showed markedly greater and more sustained vascular enhancement with Gd-copolymers.
- Gd-copolymers demonstrated confinement to the vascular space with minimal background tissue enhancement.
Conclusions:
- PEG-containing Gd-DTPA polymeric complexes show promise as blood pool MR contrast agents.
- Their enhanced efficacy in MRA may be due to vascular compartmentalization and macromolecular relaxation.
- Further studies are warranted to explore their full potential.